Search Within

Tracy B Smart-Curley

Formats
  1. Journal Article (42)
  2. Meeting Abstract (25)
  3. Conference Paper (2)
  4. Review (1)
Groups
  1. Nursing (70)
  2. Department of Medicine (62)
  3. Genitourinary Oncology Service (62)
  4. Solid Tumor Oncology Division (62)
  5. Radiology, Department of (28)
  6. Hematologic Malignancies, Division of (25)

More Groups

People
  1. Howard Scher (58)
  2. Susan Slovin (25)
  3. William Kelly (23)
  4. Michael Morris (19)
  5. Anthony De La Cruz (15)
  6. Lawrence Schwartz (14)

More People

Years
  1. 2024 (3)
  2. 2023 (1)
  3. 2022 (1)
  4. 2021 (1)
  5. 2020 (1)
  6. 2018 (1)

More Years

Publications
  1. Journal of Clinical Oncology (26)
  2. Clinical Cancer Research (8)
  3. Cancer (4)
  4. Proceedings of the American Association for Cancer Research Annual Meeting (4)
  5. Investigational New Drugs (3)
  6. Oncology Nursing Forum (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (26)
  2. American Association for Cancer Research (14)
  3. Elsevier Science, Inc. (5)
  4. Springer (5)
  5. Wiley Blackwell (5)
  6. Oncology Nursing Society (ONS) (4)

More Publishers

Results (70)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Nursing management of patients with castration-resistant prostate cancer undergoing radium-223 dichloride treatment
    Journal Article

    Delacruz, A.; Arauz, G.; Curley, T.; Lindo, A.; Jensen, T.
    Clinical Journal of Oncology Nursing (2015)

    Fulltext@MSK | Save
  • A phase II study of the androgen signaling inhibitor ARN-509 in patients with castration-resistant prostate cancer (CRPC)
    Meeting Abstract

    Rathkopf, D. E.; Shore, N.; Antonarakis, E. S.; Berry, W. R.; Alumkal, J. J.; Tutrone, R.; Saleh, M. N.; Redfern, C. H.; Hauke, R. J.; Liu, G.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A phase I study of the androgen signaling inhibitor ARN-509 in patients with metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Rathkopf, D. E.; Morris, M. J.; Danila, D. C.; Slovin, S. F.; Steinbrecher, J. E.; Arauz, G.; Curley, T.; Rix, P. J.; Maneval, E. C.; Chen, I.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A phase I trial of docetaxel and pulse-dose 17-allylamino-17- demethoxygeldanamycin in adult patients with solid tumors
    Journal Article

    Iyer, G.; Morris, M. J.; Rathkopf, D.; Slovin, S. F.; Steers, M.; Larson, S. M.; Schwartz, L. H.; Curley, T.; Delacruz, A.; Ye, Q.; more...
    Cancer Chemotherapy and Pharmacology (2012)

    Fulltext@MSK | Save
  • A phase I dose-escalation trial of vaccine replicon particles (VRP) expressing prostate-specific membrane antigen (PSMA) in patients (pts) with castration-resistant prostate cancer (CRPC): Final results
    Meeting Abstract

    Slovin, S. F.; Morris, S.; Kargman, M.; Durso, R.; Curley, T.; Israel, R. J.; Olson, W. C.; Murphy, D.; Scher, H. I.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Anti-insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody cixutumumab (cix) plus mTOR inhibitor temsirolimus (tem) in metastatic castration-resistant prostate cancer (mCRPC): Results of a phase I pilot study
    Meeting Abstract

    Rathkopf, D. E.; Danila, D. C.; Morris, M. J.; Slovin, S. F.; Borwick, L. S.; Momen, L.; Curley, T.; Arauz, G.; Larson, S. M.; Fleisher, M.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • A phase I dose escalation trial of vaccine replicon particles (VRP) expressing prostate-specific membrane antigen (PSMA) in patients (pts) with castration-resistant prostate cancer (CRPC): Preliminary results
    Meeting Abstract

    Slovin, S. F.; Kargman, M.; Durso, R.; Curley, T.; Israel, R. J.; Olson, W. C.; Morris, S.; Murphy, D.; Scher, H. I.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Phase I study of samarium-153 lexidronam with docetaxel in castration-resistant metastatic prostate cancer
    Journal Article

    Morris, M. J.; Pandit-Taskar, N.; Carrasquillo, J.; Divgi, C. R.; Slovin, S.; Kelly, W. K.; Rathkopf, D.; Gignac, G. A.; Solit, D.; Schwartz, L.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Phase 1 Trial of High-Dose Exogenous Testosterone in Patients with Castration-Resistant Metastatic Prostate Cancer
    Journal Article

    Morris, M. J.; Huang, D.; Kelly, W. K.; Slovin, S. F.; Stephenson, R. D.; Eicher, C.; Delacruz, A.; Curley, T.; Schwartz, L. H.; Scher, H. I.
    European Urology (2009)

    Fulltext@MSK | Save
  • Phase I trial of a PSMA DNA vaccine for patients (pts) with good risk renal cell carcinoma (RCC)
    Meeting Abstract

    Slovin, S. F.; Motzer, R. J.; Jefferson, M.; Gregor, P.; Wolchok, J. D.; Czarny, M.; Curley, T.; Delacruz, A.; Scher, H. I.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save